NIH Workshop on Psychedelics as Therapeutics: Gaps, Challenges and Opportunities

We're now on Instagram! Follow us @NIMHgov NEWS AND EVENTS NIH Workshop on Psychedelics as Therapeutics: Gaps, Challenges and Opportunities Date/Time: January 12 - 13, 2022 Location: Virtual The NIH Workshop on Psychedelics as Therapeutics is sponsored by NIMH, the National Institute on Drug Abuse, and the National Institute on Alcohol Abuse and Alcoholism. Hallucinogens, psychedelics, and entactogens all appear to induce similar changes in neural network growth and function and so are sometimes grouped as "psychoplastogens". Data suggest that psychoplastogens may facilitate changes in memory, behavior, and thought patterns, an effect that can be harnessed to therapeutic benefit. Therefore, the purpose of the workshop is to examine findings related to psychoplastogens in the treatment of depression, post-traumatic stress, and substance, and alcohol use disorders. Register for this workshop

NIMH Science News Questions? Contact NIMH! Director's Messages SUBSCRIBER SERVICES: Manage Preferences  |  Unsubscribe  |  Help

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Mental Health · 6001 Executive Boulevard · Bethesda, MD 20892-9663 · 1-866-615-6464